ArticleBreast cancer research : BCR2016

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

Claudette E Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.